Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal

BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Crit Care
Asıl Yazarlar: Brown, Karen S., Zahir, Hamim, Grosso, Michael A., Lanz, Hans J., Mercuri, Michele F., Levy, Jerrold H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/
https://ncbi.nlm.nih.gov/pubmed/27659071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller